Neoadjuvant Femara study highlights heterogeneity of response to AI
Provocative results:
"Gene expression changes after 14 days’ treatment with letrozole revealed different patterns of change in oestrogen regulated and proliferation genes in individual resistant tumours. Tumours could be separated into 3 different subgroups as follows: i) 9 cases in which both proliferation and oestrogen signalling signatures were generally reduced on treatment (ii) 4 cases in which both signatures were generally unaffected or increased with treatment and (iii) 2 cases in which expression of the majority of oestrogen-regulated genes decreased whereas proliferation genes remained unchanged or increased." Hopeful |
All times are GMT -7. The time now is 03:37 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021